Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study.

[1]  Q. Xu,et al.  Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy , 2022, Frontiers in Immunology.

[2]  T. Zuberbier,et al.  Development and validation of combined symptom‐medication scores for allergic rhinitis * , 2021, Allergy.

[3]  K. Saeki,et al.  Effectiveness and safety of subcutaneous immunotherapy with standardized house dust mite extract for patients under the age of 5 years: A prospective cohort study. , 2021, Allergology international : official journal of the Japanese Society of Allergology.

[4]  Y. Okamoto,et al.  Japanese guidelines for allergic rhinitis 2020. , 2020, Allergology international : official journal of the Japanese Society of Allergology.

[5]  M. Hamada.  [EVALUATION OF PROTOCOLS FOR RUSH SUBCUTANEOUS IMMUNOTHERAPY WITH STANDARDIZED HOUSE DUST MITE EXTRACTS]. , 2020, Arerugi = [Allergy].

[6]  Y. Mitobe,et al.  [DIFFERENCE BETWEEN STANDARDIZED MITE ANTIGEN AND HOUSE DUST EXTRACT IN RUSH SUBCUTANEOUS IMMUNOTHERAPY FOR CHILDREN]. , 2019, Arerugi = [Allergy].

[7]  P. Kuna,et al.  Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial. , 2018, Immunotherapy.

[8]  M. Xian,et al.  Functional and Immunoreactive Levels of IgG4 Correlate with Clinical Responses during the Maintenance Phase of House Dust Mite Immunotherapy , 2018, The Journal of Immunology.

[9]  T. Shimoda,et al.  Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trial. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[10]  Y. Ye,et al.  A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis , 2017, Allergy, asthma & immunology research.

[11]  R. Van Ree,et al.  International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. , 2016, The Journal of allergy and clinical immunology.

[12]  S. Durham,et al.  Sublingual or subcutaneous immunotherapy for allergic rhinitis? , 2016, The Journal of allergy and clinical immunology.

[13]  Y. Okamoto,et al.  Japanese Society of Allergology task force report on standardization of house dust mite allergen vaccines - secondary publication. , 2015, Allergology international : official journal of the Japanese Society of Allergology.

[14]  A. Eifan,et al.  Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial. , 2015, Journal of investigational allergology & clinical immunology.

[15]  J. Fonseca,et al.  Development process and cognitive testing of CARATkids - Control of Allergic Rhinitis and Asthma Test for children , 2014, BMC Pediatrics.

[16]  Y. Kohno,et al.  Japanese Guideline for Childhood Asthma 2014. , 2014, Allergology international : official journal of the Japanese Society of Allergology.

[17]  T. Casale,et al.  An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. , 2013, The Journal of allergy and clinical immunology.

[18]  M. Yılmaz,et al.  Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy. , 2013, Asian Pacific journal of allergy and immunology.

[19]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[20]  W. Hop,et al.  Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. , 2012, The Journal of allergy and clinical immunology.

[21]  N. Zhong,et al.  Specific IgG4 Production during House Dust Mite Immunotherapy among Age, Gender and Allergic Disease Populations , 2012, International Archives of Allergy and Immunology.

[22]  I. Barlan,et al.  A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. , 2011, The Journal of allergy and clinical immunology.

[23]  S. Spector,et al.  Allergen immunotherapy: a practice parameter third update. , 2007, The Journal of allergy and clinical immunology.

[24]  G. Canonica,et al.  Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. , 2010, The Journal of allergy and clinical immunology.

[25]  Ketan K. Sheth,et al.  Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. , 2009, The Journal of allergy and clinical immunology.

[26]  D. Larenas-Linnemann.  Subcutaneous and sublingual immunotherapy in children: Complete update on controversies, dosing, and efficacy , 2008, Current allergy and asthma reports.

[27]  Todor A Popov,et al.  Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN , 2007, Allergy.

[28]  A. Saito,et al.  Effect of home environment control on children with atopic or non-atopic asthma. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[29]  A. Cantani,et al.  A three-year prospective study of specific immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma. , 1997, Journal of investigational allergology & clinical immunology.

[30]  Jacob Cohen,et al.  A power primer. , 1992, Psychological bulletin.

[31]  M. Wickman,et al.  House dust mite sensitization in children and residential characteristics in a temperate region. , 1991, The Journal of allergy and clinical immunology.

[32]  S. Lau,et al.  High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. , 1989, The Journal of allergy and clinical immunology.